Mannatech INC: insider trades · United States · SEC (Form 4)

About Mannatech INC

Mannatech, Incorporated (ticker: MTEX) is a U.S.-listed small-cap company traded on the NASDAQ Capital Market in the United States, operating in the health and wellness industry. Founded in 1993 and headquartered in Flower Mound, Texas, the company develops and markets proprietary nutritional supplements, topical skin-care and anti-aging products, and weight-management and fitness products. Its business model is rooted in direct selling and an independent distributor network, placing it closer to a network-marketing wellness company than to a traditional pharmaceutical manufacturer. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1056358/000105635825000018/mtex-20241231.htm?utm_source=openai)) Historically, Mannatech has positioned itself as a pioneer of “glyconutrition,” a plant-based nutrition concept centered on ingredients intended to support cellular nutrition. The company highlights product families such as Ambrotose and a broader portfolio aimed at nutrition, immune health, skincare, and weight management. This gives Mannatech a distinct brand identity, but it also means the company is highly dependent on consumer trust, the perceived credibility of its product claims, and the effectiveness of its distributor ecosystem. ([us.mannatech.com](https://us.mannatech.com/products/?utm_source=openai)) From a competitive standpoint, Mannatech operates in a crowded, fragmented market where supplement brands, beauty-focused wellness companies, and direct-selling peers all compete for recurring customers and active distributors. The company’s moat is not based on scale or cutting-edge IP, but on brand loyalty, product differentiation, and network engagement. Management discloses sales across three geographic regions: the Americas, EMEA, and Asia/Pacific, showing an international footprint despite the company’s relatively modest size. Its headquarters and corporate base remain firmly anchored in the United States. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1056358/000105635825000018/mtex-20241231.htm?utm_source=openai)) Recent developments suggest continued operational consolidation and disciplined portfolio management. In the second quarter of 2024, Mannatech liquidated its Sweden entity, and its investor-relations materials show ongoing SEC reporting and a 2025 quarterly reporting cycle. The company’s recent filings and insider-activity coverage reinforce that MTEX is closely watched by microcap investors and market participants following SEC Form 4 disclosures. For investors, Mannatech is best viewed as a niche U.S. wellness platform with a long operating history, a recognizable product set, and an international sales base, but also meaningful exposure to regulatory, reputational, and channel-execution risks common in the dietary supplement sector. ([ir.mannatech.com](https://ir.mannatech.com/overview/default.aspx?utm_source=openai))